Placebo medication: Clinical Trials

14 trials of Placebo medication, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 2 recruiting, 1 terminated, 1 unknown. 6 Phase 2, 5 Phase 4, 3 Phase 3, 2 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 26Completed 5, Recruiting 1
Phase 45Completed 3, Terminated 1, Unknown 1
Phase 33Completed 3
Not applicable2Completed 1, Recruiting 1

Follow Placebo medication: new trials by email Literature Review of Placebo medication trials Research Report on Placebo medication

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer
Memantine, Placebo medication, Exercise Intervention - Breast Cancer, Locally Advanced Breast Cancer
Phase 2RecruitingUNC Lineberger Comprehensive Cancer Center902025-08-192026-05-06
Efficacy of Electroacupuncture Versus Solifenacin Succinate for Female Overactive Bladder
electroacupuncture, Solifenacin Succinate Tablets - Overactive Bladder
Not applicableRecruitingYin Ping2042023-07-072025-05-22
Chiropractic Spinal Manipulative Therapy for Acute Neck Pain
Chiropractic spinal manipulative therapy (CSMT), CSMT sham manipulation, Ibuprofen - Acute Neck Pain
Phase 4UnknownUniversity Hospital, Akershus3202022-05-232023-08-08
Naldebain for Pain Management After Knee Arthroplasty
Nalbuphine Sebacate (Naldebain), Placebo medication - Arthropathy of Knee Joint
Phase 4CompletedKaohsiung Medical University Chung-Ho Memorial Hospital802022-04-062023-03-27
Salbutamol Use in Ozone Air Pollution by People With Asthma and/or Exercise Induced Bronchoconstriction (EIB)
Salbutamol, Placebo medication, Ozone - Asthma and/or Exercise Induced Bronchoconstriction, Ozone Air Pollution
Phase 4CompletedUniversity of British Columbia182021-11-012025-03-14
A Trial of Metformin in Individuals With Fragile X Syndrome (Met)
Placebo Medication, Metformin - Fragile X Syndrome, Fragile X Mental Retardation Syndrome
Phase 2CompletedUniversity of Alberta1252019-05-242026-01-08
A Trial of Metformin in Individuals With Fragile X Syndrome
Placebo Medication, Metformin - Fragile X Syndrome, Fragile X Mental Retardation Syndrome
Phase 2 / Phase 3CompletedUniversity of California, Davis1202018-04-302025-01-17
Role of Oral Steroids in Reducing Recurrence of Urethral Stricture After Direct Vision Internal Urethrotomy
Steroid Drug, No steroid - Recurrence
Not applicableCompletedServices Hospital, Lahore1802018-01-012021-10-06
Efficacy of Riluzole in Surgical Treatment for Cervical Spondylotic Myelopathy (CSM-Protect)
riluzole, Placebo medication - Cervical Spondylotic Myelopathy
Phase 3CompletedAOSpine North America Research Network2702012-03-012018-11-02
Suppressive Therapy With Oral Antibiotics for Prevention of Postoperative Urinary Tract Infection (UTI)
Nitrofurantoin, Placebo - Urinary Tract Infection
Phase 4CompletedDuke University1632011-08-012017-02-13
Prazosin for Alcohol Dependence and Posttraumatic Stress Disorder
Prazosin, Placebo medication - Alcohol Abuse, Posttraumatic Stress Disorder
Phase 2CompletedSeattle Institute for Biomedical and Clinical Research302009-09-012020-08-25
Study of the Medication Prazosin for Alcohol Dependence
Prazosin medication, Placebo medication - Alcoholism
Phase 2CompletedSeattle Institute for Biomedical and Clinical Research922008-01-012020-06-04
Trial of Calcineurin Inhibitor-Sparing Immunosuppression Regimen in Pediatric Liver Transplantation
mycophenolate mofetil, placebo medication - End-stage Liver Disease, Renal Insufficiency
Phase 4TerminatedBaylor College of Medicine132004-11-012020-03-13
Psychosocial and Medication Treatment for Anxiety in Alcoholism
Venlafaxine, CBT, Progressive muscle relaxation therapy (PMR) - Alcohol-Related Disorders, Anxiety Disorders
Phase 2 / Phase 3CompletedBoston Medical Center1622003-09-012018-01-24

Conditions studied

Alcoholism (3)  ·  Binge-Eating Disorder (2)  ·  Chromosome Disorders (2)  ·  Congenital Abnormalities (2)  ·  Disease (2)  ·  Fragile X Syndrome (2)  ·  Genetic Diseases, X-Linked (2)  ·  Intellectual Disability (2)  ·  Nervous System Diseases (2)  ·  Neurobehavioral Manifestations (2)  ·  Sex Chromosome Disorders (2)  ·  X-Linked Intellectual Disability (2)  ·  Alcohol-Related Disorders (1)  ·  Anxiety Disorders (1)  ·  Asthma (1)

Sponsors

Seattle Institute for Biomedical and Clinical Research (2)  ·  AOSpine North America Research Network (1)  ·  Baylor College of Medicine (1)  ·  Boston Medical Center (1)  ·  Duke University (1)  ·  Kaohsiung Medical University Chung-Ho Memorial Hospital (1)  ·  Services Hospital, Lahore (1)  ·  UNC Lineberger Comprehensive Cancer Center (1)  ·  University Hospital, Akershus (1)  ·  University of Alberta (1)  ·  University of British Columbia (1)  ·  University of California, Davis (1)  ·  Yin Ping (1)

Countries

United States (8)  ·  Canada (4)  ·  China (1)  ·  Norway (1)  ·  Pakistan (1)  ·  Taiwan (1)

Top investigators

Aleksander Chaibi, PhD (1)  ·  Barza Afzal, MBBS, FCPS (1)  ·  Branko Kopjar, MD (1)  ·  Cindy Amundsen, MD (1)  ·  Domenic Ciraulo, MD (1)  ·  Francois Bolduc, MD (1)  ·  Hsuan-Ti Huang, M.D. (1)  ·  John Goss, MD (1)  ·  Michael B. Russell, Professor (1)  ·  Michael Fehlings, MD (1)  ·  Randi J Hagerman, MD (1)  ·  Tracy L Simpson, Ph.D. (1)  ·  Tracy L Simpson, PhD (1)  ·  Zev Nakamura, MD (1)

Results publications

PMID 24463669, PMID 30153753, PMID 33357512, PMID 38060549, PMID 38197642, PMID 39266323, PMID 40347099, PMID 41086299

NIH funding

K23AG086604 (1), P20AA017839 (1), R01AA013727 (1), R01AA017184 (1)